During the past decade, Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" #1 collaborator was "The Swedish Stroke Register (Riksstroke)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are "Alzheimer's Disease" (3 trials), "Atrial Fibrillation" (1 trials), "Fibrostenotic Crohn´s Disease" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" in a lesser frequency.

Most popular intervention types in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials), "BIIB092" (1 trials) and "Early start of NOAC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".